Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Specialty Chemicals

Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company`s Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is headquartered in Covington, Kentucky.
Website: ashland.com



Growth: Pretty weak revenue growth rate 0.8%, there is slowdown compared to average historical growth rates 9.6%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +9.6%. On average the margin is improving unsteadily. Gross margin is normal, +29.3%. In the last quarter the company did not beat the estimated EPS, -4.7%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 2.7%. Free cash flow yield 9.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 34.2% higher than minimum and 40.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.3x by EV / Sales multiple , the company can be 27.1% undervalued

Key Financials (Download financials)

Ticker: ASH
Share price, USD:  (0.0%)62.46
year average price 54.26  


year start price 64.07 2025-02-12

max close price 67.16 2025-02-18

min close price 46.53 2025-04-08

current price 62.46 2026-02-11
Common stocks: 53 968 050

Dividend Yield:  2.7%
FCF Yield LTM: 9.8%
EV / LTM EBITDA: 19.1x
EV / EBITDA annualized: 13.7x
Last revenue growth (y/y):  +0.8%
Last growth of EBITDA (y/y):  +80.4%
Historical revenue growth:  +9.6%
Historical growth of EBITDA:  +3.7%
EV / Sales: 1.8x
Margin (EBITDA LTM / Revenue): 9.6%
Fundamental value created in LTM:
Market Cap ($m): 3 371
Net Debt ($m): 1 168
EV (Enterprise Value): 4 539
Price to Book: 1.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-03zacks.com

ASH Q1 Earnings Beat, Sales Miss on Avoca Divestiture, Weak Demand

2026-02-02zacks.com

Ashland (ASH) Reports Q1 Earnings: What Key Metrics Have to Say

2026-02-02zacks.com

Ashland (ASH) Beats Q1 Earnings Estimates

2026-02-02globenewswire.com

Ashland reports first quarter fiscal 2026 results and narrows full-year outlook

2026-01-27prnewswire.com

Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EMEA

2025-12-24seekingalpha.com

Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data

2025-12-11globenewswire.com

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

2025-12-09globenewswire.com

Over 20 Studies of InnoCare's Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

2025-12-08globenewswire.com

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

2025-12-08businesswire.com

Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-09-30
symbol ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
filingDate 2025-11-20 2024-11-18 2023-11-17 2022-11-21 2021-11-22
acceptedDate 2025-11-20 12:32:43 2025-07-30 16:19:18 2024-11-18 16:33:00 2024-08-07 14:32:05 2024-05-01 14:34:28 2024-01-31 12:52:20 2023-11-17 13:40:39 2023-07-27 15:51:52 2023-05-03 16:03:34 2023-02-01 16:04:27 2022-11-21 16:40:21 2021-11-22 15:21:14
fiscalYear 2025 2024 2023 2022 2021
period FY Q3 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
revenue 1 824M 463M 2 113M 544M 575M 848M 2 191M 546M 603M 525M 2 391M 2 111M
costOfRevenue 1 275M 331M 1 495M 418M 435M 750M 1 523M 368M 406M 360M 1 561M 1 441M
grossProfit 549M 132M 618M 126M 140M 98M 668M 178M 197M 165M 830M 670M
researchAndDevelopmentExpenses 54M 13M 55M 15M 14M 12M 51M 12M 12M 13M 55M 50M
generalAndAdministrativeExpenses 344M 0 404M 114M 106M 0 365M 0 0 0 393M 358M
sellingAndMarketingExpenses 0 0 0 -45M -19M 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 345M 106M 404M 69M 87M 83M 365M 84M 79M 93M 393M 358M
otherExpenses 925M 721M 185M 131M -2M -2M 80M -2M 23M 23M 49M 70M
operatingExpenses 1 324M 840M 644M 84M 101M 95M 496M 120M 114M 129M 497M 478M
costAndExpenses 2 599M 1 171M 2 139M 502M 554M 845M 2 019M 488M 520M 489M 2 058M 1 919M
netInterestIncome -58M -43M -45M -62M -72M
interestIncome 5M 1 000 000 10M 3M 2M 3M 12M 2M 3M 4M 4M 1 000 000
interestExpense 63M 15M 53M 14M 13M 13M 57M 3M -10M 14M 66M 73M
depreciationAndAmortization 237M 76M 274M 104M 86M 81M 243M 62M 60M 58M 241M 244M
ebitda -509M -613M 303M 48M 125M -18M 457M 120M 143M 95M 509M 448M
ebit -746M 29M 214M 268M 204M
nonOperatingIncomeExcludingInterest -29M -55M -42M 65M -12M
operatingIncome -775M -708M -26M 42M 39M -18M 172M 62M 83M 37M 333M 192M
totalOtherIncomeExpensesNet -34M 4M 2M -9M -22M 22M -12M 2M 8M 13M -127M -57M
incomeBeforeTax -809M -704M -24M -70M 17M 4M 160M 57M 91M 50M 206M 135M
incomeTaxExpense 13M 15M -223M -101M -104M -24M -8M 15M -1 000 000 8M 25M -38M
netIncomeFromContinuingOperations -822M 199M 168M 181M 173M
netIncomeFromDiscontinuedOperations -23M -30M 10M 746M 47M
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncome -845M -742M 169M 14M 120M 26M 178M 50M 91M 40M 927M 220M
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -845M 169M 178M 927M 220M
eps -18.37 -16.13 3.45 0.28 2.4 0.57 3.36 0.96 1.68 0.74 17.17 2.85
epsDiluted -18.37 3.38 3.31 16.41 3.66
weightedAverageShsOut 46M 46M 49M 50M 50M 51M 53M 52M 54M 54M 54M 78M
weightedAverageShsOutDil 46M 46M 50M 51M 51M 51M 54M 53M 55M 55M 56M 61M
fillingDate 2025-07-30 2024-08-07 2024-05-01 2024-01-31 2023-07-27 2023-05-03 2023-02-01
calendarYear 2025 2024 2024 2024 2023 2023 2023
grossProfitRatio 0.285 0.232 0.243 0.116 0.326 0.327 0.314
ebitdaratio -1.324 0.268 0.217 -0.021 0.22 0.237 0.181
operatingIncomeRatio -1.529 0.077 0.068 -0.021 0.114 0.138 0.07
incomeBeforeTaxRatio -1.521 -0.129 0.03 0.005 0.104 0.151 0.095
netIncomeRatio -1.603 0.026 0.209 0.031 0.092 0.151 0.076
epsdiluted -16.13 0.27 2.35 0.57 0.94 1.67 0.73
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-09-30
symbol ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
filingDate 2025-11-20 2024-11-18 2023-11-17 2022-11-21 2021-11-22
acceptedDate 2025-11-20 12:32:43 2025-07-30 16:19:18 2024-11-18 16:33:00 2024-08-07 14:32:05 2024-05-01 14:34:28 2024-01-31 12:52:20 2023-11-17 13:40:39 2023-07-27 15:51:52 2023-05-03 16:03:34 2023-02-01 16:04:27 2022-11-21 16:40:21 2021-11-22 15:21:14
fiscalYear 2025 2024 2023 2022 2021
period FY Q3 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
cashAndCashEquivalents 215M 207M 300M 399M 439M 440M 417M 349M 399M 532M 646M 210M
shortTermInvestments 0 0 0 76M 77M 77M 0 0 0 0 0 0
cashAndShortTermInvestments 215M 207M 300M 475M 516M 440M 417M 349M 399M 532M 646M 210M
netReceivables 242M 201M 243M 224M 260M 194M 338M 345M 395M 351M 402M 369M
accountsReceivables 242M 242M 338M 402M 369M
otherReceivables 0 1 000 000 0 0 0
inventory 568M 567M 545M 532M 550M 588M 626M 712M 730M 724M 629M 473M
prepaids 0 0 0 0 0
otherCurrentAssets 180M 149M 107M 230M 101M 143M 125M 120M 107M 117M 91M 665M
totalCurrentAssets 1 205M 1 124M 1 195M 1 385M 1 427M 1 365M 1 506M 1 526M 1 631M 1 724M 1 768M 1 717M
propertyPlantEquipmentNet 1 304M 1 302M 1 417M 1 410M 1 457M 1 490M 1 495M 1 480M 1 475M 1 453M 1 445M 1 551M
goodwill 705M 705M 1 381M 1 352M 1 379M 1 396M 1 362M 1 383M 1 385M 1 369M 1 312M 1 430M
intangibleAssets 563M 578M 757M 761M 851M 875M 892M 916M 940M 959M 969M 1 106M
goodwillAndIntangibleAssets 1 268M 1 283M 2 138M 2 113M 2 230M 2 271M 2 254M 2 299M 2 325M 2 328M 2 281M 2 536M
longTermInvestments 424M 0 3M 423M 439M 124M 3M 129M 0 0 3M 4M
taxAssets 157M 241M 210M 160M 150M 45M 22M 20M 20M 20M 20M 30M
otherNonCurrentAssets 253M 671M 682M 256M 245M 571M 659M 575M 732M 734M 696M 774M
totalNonCurrentAssets 3 406M 3 497M 4 450M 4 362M 4 521M 4 501M 4 433M 4 503M 4 552M 4 535M 4 445M 4 895M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 4 611M 4 621M 5 645M 5 747M 5 948M 5 866M 5 939M 6 029M 6 183M 6 259M 6 213M 6 612M
totalPayables 189M 214M 210M 265M 236M
accountPayables 189M 185M 214M 198M 207M 202M 210M 210M 246M 246M 265M 236M
otherPayables 0 0 0 0 0
accruedExpenses 213M 150M 208M 269M 251M
shortTermDebt 0 19M 0 42M 21M 22M 16M 21M 20M 18M 0 374M
capitalLeaseObligationsCurrent 21M 20M 22M 19M 23M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 -202M 0 0 0 20M 0 0
otherCurrentLiabilities 0 216M 106M 224M 225M 392M 0 201M 206M 180M 0 50M
totalCurrentLiabilities 423M 420M 490M 464M 453M 414M 456M 432M 472M 464M 553M 934M
longTermDebt 1 384M 1 466M 1 349M 1 425M 1 328M 1 448M 1 314M 1 437M 1 436M 1 411M 1 270M 1 596M
capitalLeaseObligationsNonCurrent 85M 99M 106M 94M 110M
deferredRevenueNonCurrent 0 0 0 100M 101M 510M 0 545M 0 176M 0 0
deferredTaxLiabilitiesNonCurrent 31M 28M 29M 43M 148M 148M 148M 176M 175M 176M 176M 237M
otherNonCurrentLiabilities 784M 818M 810M 848M 784M 293M 818M 290M 833M 714M 900M 983M
totalNonCurrentLiabilities 2 284M 2 312M 2 287M 2 316M 2 361M 2 399M 2 386M 2 448M 2 444M 2 477M 2 440M 2 926M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 106M 103M 119M 121M 101M 129M 128M 130M 128M 113M 113M 133M
totalLiabilities 2 707M 2 732M 2 777M 2 780M 2 814M 2 813M 2 842M 2 880M 2 916M 2 941M 2 993M 3 860M
treasuryStock 0 0 0 0 0
preferredStock 0 0 0 0 0 0 0 0 0 -3 318M 0 0
commonStock 1 000 000 3M 1 000 000 0 6M 1 000 000 1 000 000 0 0 134M 1 000 000 1 000 000
retainedEarnings 2 298M 2 286M 3 315M 3 466M 3 604M 3 502M 3 595M 3 619M 3 734M 3 675M 3 653M 2 796M
additionalPaidInCapital 6M 0 4M 135M 327M
accumulatedOtherComprehensiveIncomeLoss -401M -400M -448M -499M -476M -450M -503M -470M -467M -491M -569M -372M
otherTotalStockholdersEquity 0 0 0 0 0
totalStockholdersEquity 1 904M 1 889M 2 868M 2 967M 3 134M 3 053M 3 097M 3 149M 3 267M 3 318M 3 220M 2 752M
totalEquity 1 904M 1 889M 2 868M 2 967M 3 134M 3 053M 3 097M 3 149M 3 267M 3 318M 3 220M 2 752M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 4 611M 4 621M 5 645M 5 747M 5 948M 5 866M 5 939M 6 029M 6 183M 6 259M 6 213M 6 612M
totalInvestments 424M 0 3M 499M 516M 528M 3M 129M 0 0 3M 4M
totalDebt 1 490M 1 485M 1 468M 1 446M 1 450M 1 470M 1 458M 1 458M 1 456M 1 429M 1 383M 2 103M
netDebt 1 275M 1 278M 1 168M 1 047M 1 011M 1 030M 1 041M 1 109M 1 057M 897M 737M 1 893M
fillingDate 2025-07-30 2024-08-07 2024-05-01 2024-01-31 2023-07-27 2023-05-03 2023-02-01
calendarYear 2025 2024 2024 2024 2023 2023 2023
othertotalStockholdersEquity 0 0 0 0 0 0 3 318M
totalLiabilitiesAndStockholdersEquity 4 621M 5 747M 5 948M 5 866M 6 029M 6 183M 6 259M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-09-30
symbol ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH ASH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
filingDate 2025-11-20 2024-11-18 2023-11-17 2022-11-21 2021-11-22
acceptedDate 2025-11-20 12:32:43 2025-07-30 16:19:18 2024-11-18 16:33:00 2024-08-07 14:32:05 2024-05-01 14:34:28 2024-01-31 12:52:20 2023-11-17 13:40:39 2023-07-27 15:51:52 2023-05-03 16:03:34 2023-02-01 16:04:27 2022-11-21 16:40:21 2021-11-22 15:21:14
fiscalYear 2025 2024 2023 2022 2021
period FY Q3 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
netIncome -822M -719M 199M 31M 121M 26M 168M 50M 91M 42M 181M 220M
depreciationAndAmortization 237M 122M 274M 104M 86M 77M 243M 62M 60M 59M 241M 244M
deferredIncomeTax 73M 4M -302M -1 000 000 -106M -30M -32M -4M 8M 7M -35M -26M
stockBasedCompensation 14M 2M 15M 3M 6M 1 000 000 22M 5M 5M 7M 18M 15M
changeInWorkingCapital -191M 68M 227M -60M -37M 167M -58M 46M -88M -123M -271M 80M
accountsReceivables -3M 0 96M 0 0 0 58M 0 0 0 72M 72M
inventory -28M 0 79M 0 0 0 -7M 0 0 0 41M 41M
accountsPayables -63M 0 0 0 0 0 0 0 0 0 0 3M
otherWorkingCapital -97M 68M 52M -60M -37M 167M -109M 0 0 0 -384M -36M
otherNonCashItems 783M 656M -2M 261M 162M -54M -100M -19M -33M -55M -347M 27M
netCashProvidedByOperatingActivities 94M 133M 411M 127M 54M 187M 243M 140M 43M -63M -213M 560M
investmentsInPropertyPlantAndEquipment -98M -20M -137M -29M -34M -36M -170M -44M -35M -23M -113M -105M
acquisitionsNet 16M 0 26M 0 0 0 0 3M 0 0 0 -304M
purchasesOfInvestments -54M -12M -53M -19M -11M -9M -47M -21M -15M 0 -87M -149M
salesMaturitiesOfInvestments 118M 12M 53M 42M 32M 9M 47M 21M 15M 0 87M 149M
otherInvestingActivities 15M 60M 61M 1 669M 28M
netCashProvidedByInvestingActivities -3M -51M -109M 1 556M -381M
netDebtIssuance 0 -16M 16M -615M 107M
longTermNetDebtIssuance 0 0 0 -250M 23M
shortTermNetDebtIssuance 0 -16M 16M -365M 84M
netStockIssuance -100M -380M -300M -200M -450M
netCommonStockIssuance -100M -380M -300M -200M -450M
commonStockIssuance 0 0 0 0 0
commonStockRepurchased -100M -1 000 000 -380M -130M -1 000 000 -100M -300M -158M -142M 0 -200M -450M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -76M -78M -76M -70M -70M
commonDividendsPaid -76M -78M -76M -70M -70M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -3M -5M -11M -11M -13M
netCashProvidedByFinancingActivities -179M -479M -371M -896M -426M
effectOfForexChangesOnCash 3M 39M 2M 0 1 000 000 1 000 000 8M 1 000 000 3M 3M -11M 3M
netChangeInCash -85M 39M -117M -40M -1 000 000 23M -229M -50M -133M -114M 436M -244M
cashAtEndOfPeriod 215M 207M 300M 399M 439M 440M 417M 349M 399M 532M 646M 210M
cashAtBeginningOfPeriod 300M 168M 417M 439M 440M 417M 646M 399M 532M 646M 210M 454M
operatingCashFlow 94M 133M 411M 127M 54M 187M 243M 140M 43M -63M -213M 560M
capitalExpenditure -98M -20M -137M -29M -34M -36M -170M -44M -35M -23M -113M -105M
freeCashFlow -4M 113M 274M 98M 20M 151M 73M 96M 8M -86M -326M 455M
incomeTaxesPaid 33M 53M 63M 406M 1 000 000
interestPaid 54M 52M 53M 56M 62M
fillingDate 2025-07-30 2024-08-07 2024-05-01 2024-01-31 2023-07-27 2023-05-03 2023-02-01
calendarYear 2025 2024 2024 2024 2023 2023 2023
otherInvestingActivites -43M -10M 31M 10M 29M 17M -4M
netCashUsedForInvestingActivites -63M -16M 18M -26M -12M -18M -27M
debtRepayment -50M 0 0 -16M 0 0 0
commonStockIssued 0 0 0 0 0 0 0
dividendsPaid -19M -20M -19M -20M -20M -18M -18M
otherFinancingActivites 0 -1 000 000 -1 000 000 -3M -1 000 000 -1 000 000 -9M
netCashUsedProvidedByFinancingActivities -70M -151M -20M -139M -179M -161M -27M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Earning call transcript

2025 q4
2026-02-03 ET (fiscal 2026 q1)
2025 q3
2025-11-05 ET (fiscal 2025 q4)
2025 q2
2025-07-30 ET (fiscal 2025 q3)
2025 q1
2025-05-01 ET (fiscal 2025 q2)
2024 q4
2025-01-29 ET (fiscal 2025 q1)
2024 q3
2024-11-09 ET (fiscal 2024 q4)
2024 q2
2024-08-07 ET (fiscal 2024 q3)
2024 q1
2024-05-01 ET (fiscal 2024 q2)
2023 q4
2024-01-31 ET (fiscal 2024 q1)
2023 q3
2023-11-09 ET (fiscal 2023 q4)
2023 q2
2023-07-26 ET (fiscal 2023 q3)
2023 q1
2023-05-03 ET (fiscal 2023 q2)
2022 q4
2023-02-01 ET (fiscal 2023 q1)
2022 q3
2022-11-08 ET (fiscal 2022 q4)
2022 q2
2022-07-27 ET (fiscal 2022 q3)
2022 q1
2022-04-27 ET (fiscal 2022 q2)
2021 q4
2022-02-02 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-02-02 17:11 ET
Ashland Global published news for 2025 q4
SEC form 8
2026-02-02 17:11 ET
Ashland Global reported for 2025 q4
SEC form 10
2025-11-20 17:32 ET
Ashland Global reported for 2025 q3
SEC form 8
2025-11-04 17:07 ET
Ashland Global published news for 2025 q3
SEC form 8
2025-11-04 17:07 ET
Ashland Global reported for 2025 q3
SEC form 10
2025-07-30 20:19 ET
Ashland Global reported for 2025 q2
SEC form 8
2025-07-29 21:10 ET
Ashland Global published news for 2025 q2
SEC form 8
2025-07-29 21:10 ET
Ashland Global reported for 2025 q2
SEC form 10
2025-05-01 20:04 ET
Ashland Global reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Ashland Global reported for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Ashland Global published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Ashland Global reported for 2025 q1
SEC form 10
2025-01-29 19:14 ET
Ashland Global reported for 2024 q4
SEC form 10
2025-01-29 00:00 ET
Ashland Global reported for 2024 q4
SEC form 8
2025-01-28 17:11 ET
Ashland Global published news for 2024 q4
SEC form 8
2025-01-28 17:11 ET
Ashland Global reported for 2024 q4
SEC form 10
2024-11-18 16:33 ET
Ashland Global reported for 2024 q3
SEC form 10
2024-11-18 00:00 ET
Ashland Global reported for 2024 q3
SEC form 8
2024-11-06 17:20 ET
Ashland Global reported for 2024 q3
SEC form 8
2024-11-06 17:20 ET
Ashland Global published news for 2024 q3
SEC form 10
2024-08-07 14:32 ET
Ashland Global reported for 2024 q2
SEC form 10
2024-08-07 00:00 ET
Ashland Global reported for 2024 q2
SEC form 8
2024-08-06 17:10 ET
Ashland Global reported for 2024 q2
SEC form 8
2024-08-06 17:10 ET
Ashland Global published news for 2024 q2
SEC form 10
2024-05-01 14:34 ET
Ashland Global reported for 2024 q1
SEC form 10
2024-05-01 00:00 ET
Ashland Global reported for 2024 q1
SEC form 8
2024-04-30 17:09 ET
Ashland Global reported for 2024 q1
SEC form 8
2024-04-30 17:09 ET
Ashland Global published news for 2024 q1
SEC form 10
2024-01-31 00:00 ET
Ashland Global reported for 2023 q4
SEC form 8
2024-01-30 00:00 ET
Ashland Global published news for 2023 q4
SEC form 8
2024-01-30 00:00 ET
Ashland Global reported for 2023 q4
SEC form 10
2023-11-17 00:00 ET
Ashland Global reported for 2023 q3
SEC form 8
2023-11-08 17:14 ET
Ashland Global reported for 2023 q3
SEC form 8
2023-11-01 00:00 ET
Ashland Global published news for 2023 q3
SEC form 10
2023-07-27 15:51 ET
Ashland Global reported for 2023 q2
SEC form 10
2023-07-27 00:00 ET
Ashland Global reported for 2023 q2
SEC form 6
2023-07-25 17:21 ET
Ashland Global reported for 2023 q2
SEC form 8
2023-07-25 00:00 ET
Ashland Global reported for 2023 q2
SEC form 6
2023-06-28 17:16 ET
Ashland Global published news for 2023 q1
SEC form 6
2023-06-26 17:03 ET
Ashland Global published news for 2023 q1
SEC form 6
2023-06-05 17:07 ET
Ashland Global published news for 2023 q1
SEC form 6
2023-06-05 17:06 ET
Ashland Global published news for 2023 q1
SEC form 6
2023-06-05 17:05 ET
Ashland Global published news for 2023 q1
SEC form 10
2023-05-03 00:00 ET
Ashland Global reported for 2023 q1
SEC form 8
2023-05-02 00:00 ET
Ashland Global reported for 2023 q1
SEC form 10
2023-02-01 00:00 ET
Ashland Global reported for 2022 q4
SEC form 8
2023-01-31 00:00 ET
Ashland Global reported for 2022 q4
SEC form 10
2022-11-21 00:00 ET
Ashland Global reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Ashland Global reported for 2022 q3
SEC form 10
2022-07-28 00:00 ET
Ashland Global reported for 2022 q2
SEC form 8
2022-07-26 00:00 ET
Ashland Global reported for 2022 q2
SEC form 10
2022-04-28 00:00 ET
Ashland Global reported for 2022 q1
SEC form 8
2022-04-26 00:00 ET
Ashland Global reported for 2022 q1
SEC form 10
2022-02-03 00:00 ET
Ashland Global published news for 2021 q4
SEC form 8
2022-02-01 00:00 ET
Ashland Global published news for 2021 q4
SEC form 10
2021-11-22 00:00 ET
Ashland Global published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Ashland Global published news for 2021 q3
SEC form 10
2021-07-29 00:00 ET
Ashland Global published news for 2021 q2
SEC form 8
2021-07-27 00:00 ET
Ashland Global published news for 2021 q2
SEC form 10
2021-04-29 00:00 ET
Ashland Global published news for 2021 q1
SEC form 8
2021-04-28 00:00 ET
Ashland Global published news for 2021 q1